News
Miriam Mutebi: Breast Cancer Survivor Stories and Systemic Support - Onco Daily
19+ min ago (341+ words) Miriam Mutebi, Breast Surgical Oncologist and Assistant Professor in the Department of Surgery at the Aga Khan University Hospital, shared a post on'Linked In: "Social media loves cancer survivor stories. "She fought and won." "Warrior." "Survivor." Working closely with patients…...
Ronald Chen: Renewal Application for NCI Comprehensive Cancer Center Designation
1+ hour, 56+ min ago (196+ words) Ronald Chen, Professor and Chair of the Department of Radiation Oncology at the University of Kansas Medical Center, shared a post on'Linked In: "This year, we're submitting a renewal application for the National Cancer Institute (NCI)'s comprehensive cancer center…...
Debra Patt: Advancing Progress in Patients With Advanced Cancer Requiring Cellular Therapy
2+ hour, 46+ min ago (339+ words) / Abu-Sayeef Mirza, Aimaz Afrough, Alaa Ali, Alex Sieg, Amer M. , Abu-Sayeef Mirza, Aimaz Afrough, Alaa Ali, Alex Sieg, Amer M. Beitinjaneh, Amy Moskop, Anna Sureda Balar, Attaphol Pawarode, Ayman Saad, Cameron J. Turtle, cancer, Carlos Rodriguez-Bonilla, Christine L Phillips, Christopher Strouse, Debra Patt,…...
Amer Zeidan: ASCERTAIN V and PARADIGM are Opening the Door to a Major Change of How We Treat AML - Onco Daily
2+ hour, 55+ min ago (94+ words) Amer Zeidan: ASCERTAIN V and PARADIGM are Opening the Door to a Major Change of How We Treat AML Oncodaily Amer Zeidan: ASCERTAIN V and PARADIGM are Opening the Door to a Major Change of How We Treat AML Amer…...
Amy C. Moore: Five Years After a Breast Cancer Diagnosis, A Story of Early Detection - Onco Daily
3+ hour, 11+ min ago (169+ words) Amy C. Moore, Director of Patient Engagement and Advocacy at Summit Therapeutics, Inc. , shared a post on Linked In: "Five years ago this summer, my then 76 yr old mom was diagnosed with early stage breast cancer that was caught through a…...
ESSO Hands-On Course on the Minimally Invasive Management of Peritoneal Surface Malignancies - Oncology News, Insights, Stories by Onco Daily
5+ hour, 14+ min ago (142+ words) Logarithmic Expansion of Bruce Chabner 100 Influential Cancer Survivors on Social Media: 2026 Edition FDA Approves Tregzi, the First Regulatory T-Cell Therapy for Allogeneic HSCT Check Mate 214 Updates: Nivolumab Plus Ipilimumab Versus Sunitinib in Advanced RCC Gabriela Norese: Excited to Join the…...
Maria Maddalena Laterza: Real-World Impact of Failure to Reach Surgery After Neoadjuvant Therapy - Onco Daily
5+ hour, 3+ min ago (156+ words) Maria Maddalena Laterza, Medical Oncologist at Ospedale Santa Maria delle Grazie, shared a post on'Linked In: "Excited to be presenting our poster today at ESMO GI 2026! It is a privilege to share our real-world experience on the impact of failing…...
New Report Calls for Equitable Access to Precision Cancer Medicine - European Cancer Organisation - Onco Daily
7+ hour, 50+ min ago (55+ words) European Cancer Organisation shared a post on Linked In: "Precision cancer medicine is reshaping cancer care in Europe. But access to molecular testing, biomarker-driven therapies and innovative diagnostics still depends too heavily on where a patient lives. Our new policy…...
Read News and Stories about Brain Tumour-Related Epilepsy - Oncodaily
10+ hour, 20+ min ago (124+ words) Logarithmic Expansion of Bruce Chabner 100 Influential Cancer Survivors on Social Media: 2026 Edition FDA Approves Tregzi, the First Regulatory T-Cell Therapy for Allogeneic HSCT Gabriela Norese: Excited to Join the Onco Daily Editorial Board as Reviews Editor Check Mate 214 Updates: Nivolumab…...
What Women Should Know After an Endometrial Cancer Diagnosis - Mount Sinai Medical Center - Onco Daily
9+ hour, 33+ min ago (107+ words) Mount Sinai Medical Center shared a post on Linked In: "Uterine cancer is the most common gynecologic cancer in the United States, with more than 68, 000 new cases projected for 2026. One of the main types of uterine cancer is endometrial cancer,…...